CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction
Pranjal Vaidya(Case Western Reserve University), Anant Madabhushi(Emory University), Pradnya D. Patil(Cleveland Clinic), Prateek Prasanna(Case Western Reserve University), Germán Corredor(Emory University), Prabhakar Rajiah(Southwestern Medical Center), Amit Gupta(University of Washington), Priya Velu(University of Pennsylvania), Pingfu Fu(Medical College of Wisconsin), Vamsidhar Velcheti(Cleveland Clinic), Humberto Choi(Cleveland Clinic), Niha Beig(Case Western Reserve University), Kaustav Bera(University Hospitals of Cleveland), Xiangxue Wang(Case Western Reserve University), Robert Gilkeson(University Hospitals of Cleveland), Michael D. Feldman(University of Pennsylvania)
Cited by 134
Related Papers
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416